#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Pancreatic surgery at the University Hospital Kralovske Vinohrady: 10-year review with a survival analysis for pancreatic ductal adenocarcinoma


Authors: R. Gürlich 1,2;  A. Whitley 2;  Z. Šubrt 2;  M. Oliverius 2
Authors‘ workplace: Chirurgická klinika Fakultní nemocnice Bulovka, Praha, Česká republika 1;  Chirurgická klinika Fakultní nemocnice Královské Vinohrady, Praha, Česká republika 2
Published in: Rozhl. Chir., 2024, roč. 103, č. 4, s. 132-137.
Category: Original articles
doi: https://doi.org/10.33699/PIS.2024.103.4.132–137

Overview

Introduction: The aim of the study was to summarize the results of pancreatic surgery over a ten-year period at the surgical department of the university hospital Kralovske Vinohrady and analyse the prognostic factors of pancreatic ductal adenocarcinoma.

Methods: From October 2012 to December 2022, 331 patients underwent proximal pancreatectomy, 142 patients underwent distal pancreatectomy, and 84 patients underwent total pancreatectomy. Of the total number of resected patients, the analysis was performed only in patients with proven findings of ductal adenocarcinoma of the pancreas (221 patients). Survival analysis was conducted using the Kaplan-Meier method, and prognostic factors were assessed using Cox analysis for these patients.

Results: The average length of hospitalization was 13 days (3–53 days). According to the Clavien-Dindo classification, 90 patients had an uncomplicated postoperative course, 65 had minor complications (grade I and II), and 66 patients had major complications (grade III-V). Based on TNM staging, 27 patients were in stage I, 136 in stage II, 41 in stage III, and 17 in stage IV. The median survival was 304 days. Overall, 1-, 2-, 3-, and 5-year survival rates were 62.7% (95% confidence interval (CI) 55.9%–70.4%), 39.0% (95% CI: 31.9–47.6%), 27.3% (95% CI: 20.7–36.0%), and 12.8% (95% CI: 6.9%–24.0%), respectively. Using the Cox model, the following negative prognostic factors were identified: severe postoperative complications, positive lymph nodes, T stage, and positive resection margins.

Conclusion: Pancreatic ductal adenocarcinoma is an aggressive tumour. Radical resection represents the only chance for long-term survival. The best results are achieved in specialized centres with a high volume of pancreatic resections.

Keywords:

pancreatic adenocarcinoma – pancreatic resection


Sources
  1. Whitley A, Kocián P, Nikov A, et al. Early-onset pancreatic cancer: A national cancer registry study from the Czech Republic and review of the literature. Journal of Hepato-Biliary-Pancreatic Sciences 2023;30:1324–1333. doi:10.1002/jhbp.1359.
  1. Bockhorn M, Uzunoglu FG, Adham M, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2014;155:977–988. doi: 10.1016/j.surg.2014.02.001.
  2. Dindo D, Demartines N, Clavien PA. Classification of surgical complications. Annals of Surgery 2004;240:205–213. doi:10.1097/01.sla.0000133083.54934.ae.
  3. Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 2017;161:584–591. doi:10.1016/j.surg.2016.11.014.
  4. Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 2007;142:20-5. doi:10.1016/j.surg.2007.02.001.
  1. Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007;142:761–768. doi:10.1016/j. surg.2007.05.005.
  2. Kakar S, Pawlik TM, Allen PJ, et al. Exocrine pancreas. In: Amin MB, editor, AJCC cancer staging manual, 8th, AJCC, Chicago 2017:337.
  3. International Agency for Research on Cancer (IARC). Globocan 2020: Pancreatic cancer epidemiology. Retrieved: 28.12.2023. from: https://gco.iarc.fr/today/online-analysis-table.
  4. Vuik FE, Nieuwenburg SA, Bardou M, et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut 2019;68:1820–1826. doi:10.1136/gutjnl-2018-317592.
  5. Kocián P, Svobodová I, Krejčí D, et al. Is colorectal cancer a more aggressive disease in young patients? A population-based study from the Czech Republic. Cancer Epidemiology 2019;63:101621.doi:10.1016/j.canep.2019.101621.
  1. Loveček M, Skalický P, Klos D, et al. Surgical therapy of pancreatic cancer 5 years survival. [Article in Czech] Rozhledy v chirurgii 2015;94:470–476.
  2. Tummers WS, Groen JV, Sibinga Mulder BG, et al. Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. British Journal of Surgery 2019;106:1055–1065. doi:10.1002/ bjs.11115.
  3. Ethun CG, Kooby DA. The importance of surgical margins in pancreatic cancer. Journal of Surgical Oncology 2016;113:283–288. doi:10.1002/jso.24092.
  1. Zwart ES, Yilmaz BS, Halimi A, et al. Venous resection for pancreatic cancer, a safe and feasible option? A systematic review and meta-analysis. Pancreatology 2022;22:803–809. doi:10.1016/j.pan.2022.05.001.
  1. Baláž P, Gürlich R, Havlůj L, et al. Segmental versus partial portomesenteric resection in pancreatectomy for pancreatic cancer. Journal of Surgical Research 2023;288:233–239. doi:10.1016/j. jss.2023.03.002.

prof. MUDr. Robert Gürlich, CSc.
Chirurgická klinika
FN Bulovka
e-mail:
robert.gurlich@bulovka.cz

Labels
Surgery Orthopaedics Trauma surgery
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#